ST. LOUIS, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.43 billion for the three months ended September 30, 2026, compared with $1.43 billion a year ago. Net income available to common shareholders was $224.8 million, or $1.40 per diluted common share, compared with $202.1 million, or $1.22 per diluted common share (1) for the third quart...
ST. LOUIS, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that it has made a strategic minority investment in Meow Technologies, Inc. (“Meow”), one of the leading business banking fintechs in the United States, and has entered into a services agreement under which Stifel will offer through its subsidiary bank, Stifel Bank, a white-label version of Meow's tre...
Faron Pharmaceuticals Limited (AIM:FARN) retained Stifel's ‘buy' rating and €2.50 price target after its research and development day strengthened the case for bexmarilimab, though the broker still awaits decisive BEXERA results. The bank said the event increased its confidence in the programme without disclosing major new efficacy data or materially changing its investment thesis.
BALTIMORE, Sept. 30, 2026 /PRNewswire/ -- 1919 Investment Counsel, LLC ("1919"), a subsidiary of Stifel Financial Corp. ("Stifel"), is proud to announce its inclusion in Barron's 2026 Top 100 RIA Firms list.
Stifel, the broker, has kept its ‘buy' rating and CHF25 target price on Santhera Pharmaceuticals (SIX:SANN, OTC:SPHDF, FRA:S3F0), the Swiss neuromuscular drugmaker, after first-half group revenue doubled to CHF48.3 million. The company left its 2026 guidance of CHF80 million to CHF90 million unchanged.
ST. LOUIS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for August 31, 2026, to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed.
Stifel Financial announces the addition of three senior leaders to its Venture Banking business, further solidifying its presence across the East Coast.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.